期刊
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
卷 1046, 期 -, 页码 131-137出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jchromb.2017.01.047
关键词
Topiramate; Dried blood spots; Gas chromatography-mass spectrometry; Therapeutic drug monitoring
Dried blood spots (DBS) sampling obtained from fingerpricks is a promising and patient friendly alternative for obtaining samples for drug quantification, that could be of interest for topiramate (TOP) therapeutic drug monitoring. The aim of this study was to develop and validate a simple and fast GC-MS assay for TOP measurement in dried blood spots (DBS). The method uses a liquid extraction of one 8 mm DBS, followed by a flash methylation with TMAH, and separation in a DB-5 ms capillary column. Total analytical run time was 15 min. Precision assays presented CV% lower than 9.1% and accuracy was in the range of 94.5-115%. TOP was stable at 25 and 45 degrees C up to 21 days. TOP presents saturable binding to red blood cells, resulting in a fraction in plasma (f(p)) of 0.09-0.03 at 0.8 mu g ml(-1) and 0.71-0.45 at 20 mu g ml(-1) (both at 25-50 Hct% range). The method was applied to DBS samples obtained after phlebotomy and fingerpicks from an adult individual after oral intake of 100 mg TOP (0.25-96 h post dose). Plasma and DBS concentrations were moderately correlated (r=0.61), with estimated f(p) values in the range of 0.06-0.18. Translation of TOP DES to plasma concentrations is challenging due to its concentration-dependent binding to erythrocytes. Thus, the use of whole blood concentrations for patients monitoring should be considered, which favors to the use of DBS in the clinical context. (C) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据